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Abstract 
Pneumococcal pneumonia is a leading cause of death and a major source of hu-
man morbidity. The initial immune response plays a central role in determining the 
course and outcome of pneumococcal disease. We combine bacterial titer measure-
ments from mice infected with Streptococcus pneumoniae with mathematical mod-
eling to investigate the coordination of immune responses and the effects of initial 
inoculum on outcome. To evaluate the contributions of individual components , we 
systematically build a mathematical model from three subsystems that describe the 
succession of defensive cells in the lung: resident alveolar macrophages, neutrophils 
and monocyte-derived macrophages. The alveolar macrophage response, which can 
be modeled by a single differential equation, can by itself rapidly clear small initial 
numbers of pneumococci. Extending the model to include the neutrophil response 
required additional equations for recruitment cytokines and host cell status and 
damage. With these dynamics, two outcomes can be predicted: bacterial clear-
ance or sustained bacterial growth. Finally, a model including monocyte-derived 
macrophage recruitment by neutrophils suggests that sustained bacterial growth 
is possible even in their presence. Our model quantifies the contributions of cyto-
toxicity and immune-mediated damage in pneumococcal pathogenesis. 
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Streptococcus pneumoniae (pneumococcus) is a common pathogen asso-
ciated with community acquired pneumonia, bacterial meningitis, and sec-
ondary infections following influenza (World Health Organization, 2008). 
Furthermore, pneumococcus is the causative agent in an estimated one mil-
lion deaths worldwide each year among children under 5 years of age (World 
Health Organization, 2008), particularly in developing countries. Although 
vaccination and antibiotic use have greatly reduced incidence of disease in 
all persons, the emergence of resistant strains coupled with an increase in 
incidence during influenza outbreaks (McCullers and English, 2008) has em-
phasized a need for novel treatments and a deeper understanding of pneu-
mococcal infection kinetics. 
Based on experimental studies in mice, this paper introduces a series of 
mathematical models that address the factors associated with favorable out-
comes from pulmonary pneumococcal infections. These models track three 
stages of immune cell recruitment to identify how each cell type controls 
bacterial dynamics and the likelihood of host survival. 
1.1. Innate Immune Response to S. pneumoniae 
Pneumococci colonize the nasopharynx in up to 70% of young children 
(Giebink, 2001) and 40% of healthy adults (Austrian, 1986), and asymp-
tomatic carriage may last up to 6 weeks in an individual (Orihuela and Tuo-
manen, 2006). However, pneumococci can migrate to the lungs resulting in a 
more serious infection. Nevertheless, only a small fraction of carriers develop 
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reflects the efficiency of host defenses as most disease occurs when pathogen 
removal systems, such as ciliated epithelium and mucin entrapment , are com-
promised either due to preceding viral infections or underlying respiratory 
conditions (Kadioglu et al. , 2008). In addition to host characteristics, both 
the pathogen strain and inoculum size determine whether a pneumococcal 
population can establish within a host (Kadioglu et al., 2008). 
When host barriers are breached, three types of cells arrive sequentially 
and destroy pneumococci through phagocytosis: resident alveolar macro-
phages (AMs), neutrophils, and monocyte-derived macrophages (MDMs). 
Alveolar macrophages play an important role in the defense against airborne 
pathogens and provide the first line of cellular defense against a pneumococ-
cal lung infection (Dockrell et al., 2003; Gwinn and Vallyathan, 2006; Taylor 
et al. , 2005). These cells phagocytose bacteria that reach the terminal bron-
chioles and alveoli (Franke-Ullmann et al., 1996; Jonsson et al., 1985) , and 
coordinate the innate immune response to infection (Kadioglu and Andrew, 
2004; Knapp et al. , 2003). It is thought that when the ratio of pneumococci 
to phagocytes does not exceed some critical, although unknown, number, 
AMs can successfully phagocytose and kill pneumococci (Knapp et al., 2003). 
However , as this ratio increases for larger initial pneumococcal inoculums, 
AMs are unable to eradicate all pneumococci. Alveolar macrophages also 
secrete proinflammatory cytokines, such as interleukin-1 (IL-1) and tumor 
necrosis factor alpha (TNF -0:) , to initiate the inflammatory response and re-
cruit activated neutrophils into the lung (Monton and Torres, 1998; Zhang 
et al., 2000). 
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4 hours postinoculation (pi) and dominate the initial inflammatory immune 
response. A rapid reduction of neutrophil numbers follows a peak 24-48 hours 
pi, even when bacterial titers remain high (Bergeron et al., 1998; Duong 
et al. , 2001; Fillion et al. , 2001; Kadioglu et al., 2000). This swift decrease 
in neutrophils is paralleled by MDM infiltration at 48 hours pi (Fillion et al. , 
2001). Nevertheless, pneumococcal growth can remain unbounded causing 
100% mortality in mice within 5 days at higher inocula (Bergeron et al., 1998; 
Duong et al., 2001; Fillion et al., 2001), indicating a limit to the phagocytic 
capacity of all three types of cells (Clawson and Repine, 1976; Onofrio et al., 
1983) and a potential for significant inflammation to occur. 
These phenomena suggest that a three-stage phagocytic response is criti-
cal for clearance of larger inocula and that skewing of the innate response may 
have a profound impact on the outcome. Although it is known that effective 
phagocytosis is not the only factor determining pneumococcal pathogene-
sis, we aim here to capture some of the complexities of the innate immune 
response to pneumococcus by developing mathematical models for the three-
stage phagocytic response and testing them with data on artificially infected 
mice. 
1.2. Mathematical Models of Bacterial Kinetics 
Previously published mathematical models of bacterial kinetics and in-
flammatory processes present a conceptual framework to examine two phe-
nomena of interest here (Lauffenburger, 1985; Pilyugin and Antia, 2000; 
Reynolds et al., 2006; Rudnev and Romanyukha, 1995): (i) the initial dose 
threshold, and (ii) the observed variations in outcome (clearance vs sustained 
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equations to describe bacterial pathogenesis and often divide phagocytic cells 
into a variety of different subpopulations. To address these behaviors , one 
study split the macrophage population into cells that are in a free state (i .e., 
not associated with bacteria) and cells that are engaged in active phagocyto-
sis of bacteria (Pilyugin and Antia, 2000) , and suggested that the "handling" 
time of bacteria limited the ability of macrophages to fully eradicate a bac-
terial population. 
Other models include two separate subsets of phagocytes, neutrophils 
and macrophages (Lauffenburger, 1985; Rudnev and Romanyukha, 1995), 
and show that different behaviors are possible with various initial condi-
tions. However, the models did not have these cells arriving sequentially, 
and the macrophage response included either only recruited macrophages 
(Rudnev and Romanyukha, 1995) or a single equation combining resident 
alveolar macrophages and MDMs (Lauffenburger, 1985). More commonly, 
however , models include only one subset of phagocytes. For example, a sin-
gle type of macrophage was useful in a model that evaluated the importance 
of prolonged inflammation in the context of sepsis, and emphasized antiin-
flammatory cytokines and tissue damage as the factors influencing infection 
outcomes (Reynolds et al. , 2006). 
Many of these models describe "generic" bacterial dynamics. However, 
differences among bacterial species render most prior formulations inappro-
priate for a pneumococcal lung infection. In particular, the succession of 
neutrophil and MDM accumulation depends on bacterial type and differs be-
tween various gram-positive bacteria and gram-negative bacteria (Schluger 
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domonas aeruginosa (gram-negative) is similar to pneumococcus (gram-posi-
tive) in that neutrophils are the predominant phagocyte. However, neu-
trophils may appear simultaneously with MDMs during infections with Kleb-
siella pneumoniae (gram-negative) and Staphylococcus aureus (gram-positive) 
(Toews et al., 1979). This variation has been attributed to a distinct , but 
partially overlapping, set of cytokines induced by different species during 
bacterial colonization (Schluger and Rom, 1997). 
Few existing models have sufficient experimental data for validation and 
parameterization, and no models specific to S. pneumoniae have been de-
veloped. We capitalize on the power and convenience of the mouse model 
system to compare the kinetics of three bacterial doses over the course of 
an infection and infer possible interactions between pneumococci and host 
immune responses. We infected groups of BALB / cJ mice with three different 
inocula of S. pneumoniae strain D39 and obtained bacterial measurements 
from the lungs of individual mice. 
U sing these data as a guideline, we develop mathematical models that 
describe the kinetics of each of the three stages. We find a single equation 
that characterizes the alveolar macrophage response, and use this equation 
to determine how an initial dose threshold arises. We then extend the model 
to incorporate proinflammatory cytokine production and the resulting neu-
trophil recruitment, and establish that two outcomes, clearance or sustained 
bacterial growth, are possible. Lastly, we examine the possibility of bacterial 
clearance given an influx of monocyte-derived macrophages. Through each 
of these models, we gain a better understanding of the extent to which AMs, 
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terial ("debris") contribute to the initiation and resolution of a pneumococcal 
lung infection. 
2. Experimental Data 
2.1. Methods and Materials 
2.1.1. Mice 
Adult (6-8 wk old) female BALB/cJ mice were obtained from Jackson 
Laboratories (Bar Harbor, ME). Mice were housed in groups of 4-6 mice in 
high-temperature 31.2 cm x 23.5 cm x 15.2 cm polycarbonate cages with 
isolator lids. Rooms used for housing mice were maintained on a 12:12-hour 
light:dark cycle at 22 ± 2°C with a humidity of 50% in the biosafety level 2 
facility at St. Jude Children's Research Hospital (Memphis, TN). Prior to 
inclusion experiments, mice were allowed at least 7 days to acclimate to the 
animal facility. Laboratory Autoclavable Rodent Diet (PMI Nutrition Inter-
national, St. Louis, MO) and autoclaved water were available ad libitum. 
All experiments were performed in accordance with the guidelines set forth 
by the Animal Care and Use Committee at St. Jude Children's Research 
Hospital. 
2.1.2. Infectious Agents and Model 
S. pneumoniae strain D39 (type 2) was transformed with the lux operon 
(Xenogen) (McCullers and Bartmess, 2003). For infection experiments, bac-
teria were diluted in sterile phosphate buffered saline (PBS) and administered 
at a dose of 104 , 105 or 106 colony forming units (CFU) intranasally to groups 
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IL) in a total volume of 100~1 (50~1 per nostril). Mice were weighed at the 
onset of infection and each subsequent day for illness and mortality. 
2.1.3. Lung Titers 
Mice were euthanized by C02 asphyxiation. Lungs were aseptically 
harvested, washed three times in PBS, and placed in 500~1 sterile PBS. 
Lungs were mechanically homogenized using the Ultra-Turrax T8 homoge-
nizer (IKA-werke, Staufen, Germany). Lung homogenates were pelleted at 
10,000 rpm for 5 minutes and the supernatants were used to determine the 
bacterial titer for each set of lungs using serial dilutions on tryptic soy-agar 
plates supplemented with 3% (vol/vol) sheep erythrocytes. 
2.2. Experimental Results 
Infecting mice with an initial inoculum of 104 CFU resulted in unde-
tectable bacterial lung titers 4 hours pi. We found that a dose above 104 
CFU is necessary to induce a pneumococcal lung infection with the type 2 
strain D39. The groups of mice given an initial dose of 105 CFU had bacterial 
titers initially increase exponentially for 8 hours, drop briefly at 16 hours pi 
then reach peaks up to 5.8 X 107 CFU /mllung homogenate at 24 hours pi. 
Bacterial lung titers then declined rapidly and, in all but one sample, became 
undetectable at 48 hours pi. All mice in the 72-hour group had completely 
cleared the infection (Figure 1). 
Mice inoculated with 106 CFU had bacterial titers at significantly high 
levels by 4 hours pi, which reached peaks as high as 2.3 x 108 CFU /mllung 
homogenate by 16 hours pi. Titers began to decline thereafter; however, 
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Figure 1: Pneumococcal lung titers (geometric means ± SD) over time for groups of 6 
mice inoculated with 105 (squares) or 106 (triangles) CFU. Titers for mice given 104 CFU 
were undetectable and are not shown. The dotted line represents a lower detection limit . 
in these mice, which showed sustained bacterial titers 72 hours pi (Figure 1). 
Elevated bacterial titers over several days coupled with significant weight loss 
(data not shown) suggested these mice had severe pneumonia. All but one 
mouse (72-hour group) survived the experiment. 
3. Mathematical Model 
3.1. Methods and Materials 
Numerical simulation of model equations was done in Matlab using the or-
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model and the neutrophil model, and using the delay differential equation 
(DDE) solver dde23 for the monocyte-derived macrophage model. Parameter 
values used to simulate each model are given in Tables 1-3 and descriptions 
of the chosen values are given in the text. 
3.2. Stage 1: The Alveolar Macrophage Response 
Alveolar macrophages are part of the initial host defense that respira-
tory pathogens encounter when entering the airway. These cells are thought 
to tightly regulate growth of small pneumococcal populations but become 
insufficient with larger initial inocula. This limitation may explain the de-
pendency of initial acquisition on inoculum size, as both we and others have 
found for a pulmonary pneumococcal infection (Sun and Metzger, 2008). 
To investigate the dosage threshold, we developed a mathematical model 
(Equation (2)) that depicts the interaction between a pneumococcal popu-
lation (P) and the resident alveolar macrophages (MA). Pneumococci grow 
logistically at a rate r per hour with a maximum tissue carrying capacity, 
Kp CFU Iml, and are phagocytosed at rate rMAf(P, M A ) per cell per hour, 
where 
XM f( P M ) - n A 
, A - PX + nXMA (1) 
Equation (1) represents a decrease in phagocytosis with large pneumococcal 
population size. The shape parameter x describes the rate of consumption 
of pneumococci (Figure 2(a)). The value of n gives the ratio of bacteria to 
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Figure 2: The function (f(P, M A )) describing the decrease in phagocytosis of pneumococ-
cus by alveolar macrophages for various values of (a) the nonlinearity parameter x, and 
(b) the maximum number of pneumococci per alveolar macrophage, n. Vertical line at 
P(t) = 104 shows the difference in f(P, M A) given a particular value of n. MA is fixed at 
106 cells. 
for a given inoculum size (Figure 2(b)). 
Although alveolar macrophages were once thought to locally proliferate 
rather than derive from blood monocytes (Coggle and Tarling, 1982, 1984; 
Tarling et al. , 1987) , recent studies do not support this view (Murphy et al. , 
2008; Taut et al., 2008). We assume AMs are supplied at a constant rate 
of s cells per hour with a clearance rate d, for simplicity. We do not con-
sider pneumococcal-ind uced death of AMs (Maus et al., 2004) as this effect 
would likely be minimal in the early stages of infection kinetics . Alveolar 
macrophage population dynamics are slow compared to bacterial clearance, 
so we take these cells to be in quasi-steady state such that M'A = s / d. 
We term this model "the alveolar macrophage model", which has dynam-
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(2) 
3.2.1. Parameter Identification 
We did not use a sophisticated scheme to estimate parameter values be-
cause this model is designed to capture only the initial dose threshold and 
would fit at most 1-2 data points. We instead use parameter values available 
in the literature where possible and selected others to match the data by 
tuning values based on biologically feasible ranges (Table 1). 
We set the steady state value of alveolar macrophages to M'A = 106 cells, 
the estimated number that reside in a murine lung (van Gud Alblas and van 
Furth, 1979). Estimates of the turnover rate of alveolar macrophages range 
from 10-40 days (Coggle and Tarling, 1982; Godleski and Brain, 1972; van 
Gud Alblas and van Furth, 1979), although recent evidence suggests a longer 
life-span (Murphy et al., 2008). This corresponds to 0.001 :::; d :::; 0.0042 
implying s = 1.0-4.2 X 103 cells per hour. Based on the maximum bacterial 
titer measured in our own experiment, we fix Kp = 2.3 X 108 CFU jml. 
The three initial values of pneumococci (Po) were chosen as 103 , 104 , and 
105 CFU jml. The units of these values (CFU per ml of lung homogenate) 
differ from the units of initial inocula (CFU) used in the experiments. We 
assume only a portion of bacteria reach the lungs since some bacteria could 
be quickly trapped in the airway and removed by mucocilliary mechanisms. 
These values were chosen such that the data could be reproduced and to 
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The doubling time of pneumococcal strain D39 is estimated to be 84 
minutes when injected intravenously in a mouse model of sepsis (Benton 
et al. , 1995). In contrast, the calculated doubling time in blood media is 
20-30 minutes (Todar, 2002). Because we could not establish an exact value 
of the growth rate in the lung, we explored values between 20-84 minutes to 
determine which produced the best fit. We chose r = 11.3 x 10-1 per hour, 
corresponding to a doubling time of approximately 37 minutes. 
The maximum number of pneumococci associated with an alveolar macro-
phage (n) was set to 5 CFU Iml per cell , based on a study that found, on 
average, 5 pneumococci bound to each human AM (Gordon et al. , 2000) and 
since the lung homogenate is typically 1-1.5 ml. We fix the degree of nonlin-
earity (x) in the function f(P, MA ) to a value of 2 based on our experimental 
findings that phagocytosis is decreased for initial inocula greater than 104 
CFU (i.e. , 103 CFU Iml) . Lastly, we found that 1MA = 5.6 X 10-6 per cell 
per hour (i.e. , 1MA MA = 5.6 per hour) could predict the observed bacterial 
titers. We find this value reasonable as the estimated killing rate of S. aureus 
by neutrophils is 6.9 per hour (Hampton et al., 1994). 
13 
Table 1: The alveolar macrophage model (Stage 1) parameter definitions and values.
Parameter Description Units Value Comments
r Bacterial growth rate hour−1 11.3× 10−1 see text
KP Bacterial carrying capacity CFU/ml 2.3× 10
8 see text
γMA Bacterial clearance by AMs cell
−1hour−1 5.6× 10−6 see text
n Maximum number bacteria per AM (CFU/ml)cell−1 5 (Gordon et al., 2000)
x Nonlinearity in f(P,MA) N/A 2 see text
s AM constant supply cell−1hour−1 1.0− 4.2× 103 see text
d AM death rate hour−1 1.0− 4.2× 10−3
(Coggle and Tarling, 1982; Godleski




AM steady state value cells 106 (van Oud Alblas and van Furth, 1979)
P0 Initial number of pneumococci CFU/ml 10
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3.2.2. Results - Alveolar Macrophage Model 
We solved Equation (2) numerically with the parameter values specified in 
Table 1. For an initial pneumococcal value of Po = 103 CFU jml, the number 
of resident alveolar macrophages is large enough that bacterial titers decline 
immediately (Figure 3). A dose one log higher (Po = 104 CFU jml) results in 
a short lag (rv3 hours) in bacterial growth as AMs initially limit exponential 
bacterial replication. Shortly after, however, pneumococci overwhelm the 
AM response and reach a steady-state value of P(t) = K p . This slowed 
initial growth phase is not evident with a higher initial value (Po = 105 
CFU jml) where immediate bacterial growth occurs. 
These results imply that a decreased ability of resident alveolar macro-
phages to efficiently phagocytose large densities of pneumococci can produce 
a dosage threshold. Our model predicts that bacterial titers would quickly 
reach a maximum capacity which could then result in death of the host 
without additional components of the immune response. 
3.3. Stage 2: The Neutrophil Response 
U sing the alveolar macrophage model, we found that resident alveolar 
macrophages could provide protection against a low-dose challenge of pneu-
mococci, partial clearance of an intermediate dose , but no visible effects on a 
high-dose challenge (Figure 3). When AMs cannot control bacterial growth 
through phagocytosis, their main effect switches to modulating the inflam-
matory response by recruiting neutrophils to the infected lung (Jones et al. , 
2005; Mizgerd et al., 1996). We build upon Equation (2) to incorporate 
proinflammatory cytokine production that induces neutrophil migration and 
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Figure 3: Numerical simulation of the alveolar macrophage model, Equation (2), using 
initial conditions Po = 103 CFU jml (dashed-dotted line) , Po = 104 CFU jml (dashed 
line) , and Po = 105 CFUjml (solid line). Pneumococcal titers (geometric means ± SD) 
are shown for mice inoculated with 105 (squares) or 106 (triangles) CFU. Titers for mice 
given 104 CFU were undetectable and are not shown. The dotted line represents a lower 
detection limit. 
3.3.1. Cytokine Production 
Pneumococcal entry into the lung prompts the release of proinflamma-
tory cytokines such as IL-1 and TNF-a (Bergeron et al., 1998). Alveolar 
macrophages produce a wide array of cytokines (Monton and Torres, 1998) , 
and alveolar epithelial cells also secrete cytokines following pneumococcal at-
tachment and/or cytotoxic injury (Maus et al. , 2004; McRitchie et al. , 2000; 
Stadnyk, 1994). Both IL-1 and TNF-a have been shown to increase rapidly 
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(Bergeron et al. , 1998). 
Although these two cytokines have slightly different kinetics (Bergeron 
et al., 1998), we include both as the single variable C (Equation (9)). We 
divide the alveolar macrophage class into two subsets: M R , representing AMs 
in a resting state that are not releasing cytokines, and Me , representing AMs 
actively secreting cytokines. Alveolar macrophages in the MR class become 
activated at rate eM P due to interaction with bacteria and are deactivated at 
rate rt, per hour . Equations (3)-(4) are the subsystem describing this process, 
dMR ~ = S - dMR - eMPMR + rt,Me (3) 
dMe ~ = eMPMR - rt,Me - dMe · (4) 
We assume that the total AM population remains constant, MA = MR+Me , 
and that the activation process is rapid when AMs encounter pneumococci. 
Thus, the number of alveolar macrophages that release cytokine is 
(5) 
when we assume that the Me population reaches a quasi-steady state. The 
rate of cytokine production from these cells is v pg/ml per hour. 
To model cytokine production from tissue injury, we consider two popu-
lations of epithelial cells: target cells not associated with pneumococci (Eu, 
Equation (7)) and cells with pneumococci attached to cell surface receptors 
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eration occurs within 3-5 days (Adamson et al., 1988; Ramphal et al., 1980) , 
so we do not consider a source of new target cells. Pneumococci adhere to 
cells at a rate wP per hour. Cells with bacteria attached are lost , either from 
toxic effects of the bacteria or by immune-mediated mechanisms, at a rate dE 
per hour. Cytokines are produced at a rate 0: pg/ml per hour from epithelial 
cells and are degraded at a rate de per hour. 
Antiinflammatory cytokines (e.g. , IL-I0) and other signaling molecules 
(e.g., nitric oxide (NO)) produced by alveolar macrophages and neutrophils 
during a pneumococcal infection aid regulation of the inflammatory process 
(Bergeron et al. , 1998; Bingisser and Holt , 2001 ; Marriott et al., 2004; van der 
Poll et al. , 1996; Thomassen et al., 1997) . For simplicity, we do not explicitly 
include products such as IL-I0 or NO in our model. Instead, we incorporate 
cytokine inhibition from neutrophil (N) effects by reducing production by a 
factor of 1 + knN. 
3.3. 2. Neutrophil Recruitment 
The signaling from proinflammatory cytokines recruits neutrophils (N , 
Equation (10)) at a rate TJ cells per pg/ml per hour which are then cleared 
at a rate dN per hour. We do not include a limitation of the phagocytic 
rate ("iN ) of neutrophils but we do set the maximum number of neutrophils 
present in the lung at Nmax . 
Neutrophil exposure to pneumococci results in apoptosis and, at high in-
ocula, necrosis (Zysk et al. , 2000). The effect of this process is two-fold. First , 
phagocyte apoptosis following bacterial colonization decreases inflammation 
and contributes to host recovery (DeLeo, 2004). Alveolar macrophages play 
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airway (Dockrell et al., 2001 , 2003). However, when apoptotic and necrotic 
material is not efficiently removed, tissue damage increases and bacterial 
growth may be increased. 
We incorporate both the influence of pneumococcal-induced neutrophil 
apoptosis (dN p) and the role of alveolar macrophages in this process. To 
understand the effect of cell death on pathogenesis, we introduce a state vari-
able to account for the accumulation of debris (D, Equation (11)), which has 
arbitrary units. In our model , neutrophil death , both natural and bacterial-
induced, and the death of epithelial cells translate into debris at rates PI, 
P2 and P3 per cell, respectively. Alveolar macrophages then eliminate excess 
debris at a rate dD per hour. While AMs are engaged in clearing the air-
way of dead material, we assume their ability to phagocytose pneumococci 
is inhibited by a factor 1 + kd D M'A. 
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3.3.3. Results - Neutrophil Model 
The large number of parameters in our model restricts our ability to 
fit Equations (6)-(11) to the data. Therefore, most parameter values were 
chosen based on searches in biologically realistic ranges that matched the 
data, although we fix some values (de and dN ) based on estimates reported 
in the literature (Gloff and Wills, 1992; Malech, 2007). The initial number 
of epithelial cells was set at Eu(O) = 108 cells , based on a calculation of 
the number of cells residing in the murine lung (Stone et al. , 1992), and the 
initial values of the remaining state variables (C, N, and D) were set to zero. 
All other parameter values are listed in Table 2. 
Simulating Equations (6)-(11) with three different initial pneumococcal 
conditions (103 , 104 and 105 CFU Iml) shows three distinct outcomes (Fig-
ure 4a). A low dose , Po = 103 CFU Iml, is immediately cleared by alveolar 
macrophages and does not result in noticeable cytokine production or neu-
trophil recruitment (Figure 4c, b ). 
20 
Table 2: The neutrophil model (Stage 2) parameter def-
initions and values.
Parameter Description Units Value Comments
γN Bacterial clearance by neutrophils cell
−1hour−1 1.0× 10−5 see text
θM Activation of cytokine production (CFU/ml)
−1hour−1 4.2× 10−8 see text
κ Deactivation of cytokine production hour−1 4.2× 10−2 see text
ν Cytokine production by AMs (pg/ml)cell−1hour−1 2.9× 10−2 see text
ω Bacterial attachment to epithelial cells (CFU/ml)−1hour−1 2.1× 10−8 see text
dE Epithelial cell death hour
−1 16.7× 10−2 see text
α Cytokine production by epithelial cells (pg/ml)cell−1hour−1 2.1× 10−2 see text
kn Cytokine inhibition by neutrophils cell
−1 1.4× 10−5 see text
dC Cytokine degradation rate hour
−1 8.3× 10−1 (Gloff and Wills, 1992)
Nmax Maximum number neutrophils cells 1.8× 10
5 see text
η Neutrophil recruitment rate cells (pg/ml)−1hour−1 13.3× 10−1 see text
dN Neutrophil clearance rate hour
−1 6.3× 10−2 (Malech, 2007)
dNP Bacterial-induced death neutrophils (CFU/ml)
−1hour−1 2.5× 10−7 see text
ρ1 Debris from bacterial-induced neutrophil death cell
−1 1.0× 10−1 see text
ρ2 Debris from neutrophil death cell
−1 1.0× 10−3 see text
ρ3 Debris from epithelial cell death cell
−1 1.0× 10−5 see text
dD Removal of debris by AMs cell
−1 2.5× 10−6 see text
kd Phagocytosis inhibition cell
−1 5.0× 10−9 see text
21
Table 2 – Continued
Parameter Description Units Value Comments
P (0) Initial number of pneumococci CFU/ml 103, 104 or 105 see text
EU(0) Initial number of epithelial cells cells 10
8 (Stone et al., 1992)
EA(0) Initial number of epithelial cells with bacteria cells 0 see text
C(0) Initial concentration pg/ml 0 see text
N(0) Initial number of neutrophils cells 0 see text
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At an intermediate value (Po = 104 CFU jml), the lag in bacterial growth 
initially from clearance by alveolar macrophages is reinforced by the appear-
ance of neutrophils in the lung, which extends the delay in exponential bac-
terial growth from 3 hours to 6 hours (Figure 4a). Pro inflammatory cytokine 
production is initially slow but increases rapidly thereafter and reaches a peak 
24 hours pi (Figure 4c). These dynamics agree with experimental measure-
ments of both IL-1 and TNF-a (Bergeron et al., 1998). Paralleling cytokine 
dynamics, neutrophils increase rapidly and peak 36 hours pi before slowly 
declining over several days (Figure 4b) , also consistent with empirical obser-
vations (Fillion et al., 2001). The migration of neutrophils into the infection 
site effectively controls bacterial growth, which peaks 16 hours pi. Elimina-
tion of bacteria slows between 48-72 hours pi corresponding to a decrease in 
neutrophil numbers. At this time, alveolar macrophages are freed up from 
debris removal and return to phagocytosis of pneumococci. It is unclear 
whether or not this occurs biologically; however, it is possible that AMs are 
responsible for the completion of bacterial eradication. During the course of 
the infection, only a fraction (rv65%) of epithelial cells are killed as a result 
of bacterial adherence (Figure 4e,f). 
The neutrophil response is not sufficient to clear a high dose inoculation. 
For Po = 105 CFU jml, bacterial growth slows briefly within 3 hours pi in ac-
cordance with a sharp rise in both neutrophils and proinflammatory cytokine 
concentration (Figure 4a,b,c). However, pneumococcal-induced neutrophil 
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Figure 4: Numerical simulation of the neutrophil model, Equations (6)-(11), using initial 
conditions Po = 103 CFU/ml (dashed-dotted line) , Po = 104 CFU/ml (dashed line), 
Po = 105 CFU /ml (solid line), and parameter values in Table 2. (a) Bacteria against 
titer data (squares - 105 CFU /mouse, triangles -106 CFU /mouse), (b) neutrophils, (c) 
proinfiammatory cytokine, (d) debris, (e) susceptible epithelial cells, and (f) epithelial 
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point , 24 hours pi , bacterial titers rise quickly and reach the maximum tissue 
carrying capacity (Kp). In addition, a significant amount of debris results 
from both the cytotoxic effects on neutrophils and epithelial cells. In this 
case, all target cells are killed by pneumococcal attachment. 
We next simulated Equations (6)-(11) with additional values of Po to 
determine the extent to which outcomes are altered with small changes in the 
initial condition. As illustrated in Figure 5, the alveolar macrophage response 
is sufficient for all initial values under Po = 104 CFU jml and bacterial titers 
decline rapidly. However, for initial conditions larger than Po = 104 CFU jml, 
bacteria grow exponentially with an evident lag phase in only a small region 
around this value. The length of time that bacterial growth is controlled by 
neutrophils decreases as Po increases, with complete clearance possible below 
some critical value of Po (3.98 x 104 CFU jml, compared to 9.99 x 103 with 
AMs only). These dynamics correspond to an unstable equilibrium between 
P(t) = 0 and P(t) = K p , although we were not able to find this value 
analytically. 
3.4. Stage 3: The Monocyte-Derived Macrophage Response 
Although neutrophils dominate the early cellular influx of leukocytes (i.e., 
white blood cells) into sites of pulmonary pneumococcal infections (Mizgerd 
et al., 1996), these cells are replaced by monocyte-derived macrophages later 
during inflammation (Fillion et al., 2001). The shift to MDM recruitment 




























































T ,i/ T 
--' 













' '''''''''''''''''' '' '' ' '''''''' ' '''''''''''' ' '' '' '''''''''''. '' " '"'' 
! Po=1 .0X103 CFU/ml o ,! ""'" ,- ,-, 
~ D,. 106 CFU, Mean ± S 
_ 1 ~ • 105 CFU, Mean ± S 
• 







Figure 5: Numerical simulation of the neutrophil model, Equations (6)-(11), with the 
parameter values in Table 2 and various initial values of bacteria: Po = 103 CFU /ml 
(dashed-dotted line) , Po = 5.6 X 103 CFU/ml (solid orange line), Po = 104 CFU/ml 
(dashed line), Po = 1.8 X 104 CFU/ml (solid green line), Po = 5.6 X 104 CFU/ml (solid 
yellow line), Po = 105 CFU /ml (solid black line), and parameter values in Table 2. 
(Doherty et al., 1988). However, other studies suggest the switch may be the 
result of MDM response to chemokines produced by tissue cells (Henderson 
et al. , 2003) or regulation by the cytokine 1L-6 (Kaplanski et al., 2003). 
The delayed appearance of MDMs also correlates with macrophage-colony 
protein 1 (MCP-1) production (Fillion et al., 2001), NO release (Bergeron 
et al. , 1998) , and bacterial formyl peptide production (Fillion et al. , 2001) , 
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Rather than including the dynamics of cytokines such as 1L-6, MCP-l, 
or NO, we assume MDM recruitment is proportional to the neutrophil pop-
ulation. Furthermore, we found it beneficial to assume that MDMs appear 
T time units after neutrophils at a rate ~ per hour , where the number of 
macrophages cannot exceed Mmax (Equation (18)). Clearance of these cells 
occurs at a rate dm per hour. We exclude macrophage apoptosis in response 
to the bacterial challenge since it has been shown to be delayed (Dockrell 
et al. , 2001; Marriott et al. , 2004). We also exclude the contribution of 
macrophage death to debris assuming that the effect is small. Recruited 
macrophages phagocytose pneumococci at a rate 1m per cell per hour. Com-
bining these dynamics with Equations (6)-(10) results in "the monocyte-
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(18) 
3.4. 1. Results - Monocyte-Derived Macrophage Model 
With parameters in Table 3, this model exhibits the observed behavior of 
bacterial kinetics for all three initial conditions of pneumococci (Figure 6a). 
Recruited macrophages (Figure 6d) are evident starting at 24 hours pi and 
peak between 72 and 96 hours pi for an intermediate initial value of pneumo-
cocci (104 CFU jml). This is consistent with experimental findings (Fillion 
et al., 2001) and corresponds to successful elimination of bacteria, which oc-
curs 24 hours earlier with these cells present than with neutrophils and AMs 
only. Furthermore, the threshold value of Po such that bacterial eradication 
occurs is 2.5 times more when macrophages are recruited than with neu-
trophils and AMs only (9.97 x 104 vs 3.98 X 104 CFU jml). For high initial 
Table 3: The monocyte-derived macrophage model (Stage 3) parameter definitions and 
values. 
Parameter Description Units Value 
1m Bacterial clearance by MDMs cell-1 hour-1 3.2 x 10-5 
Mmax Maximum number of MDMs cells 1.8 x 105 
~ MD M recruitment rate hour- 1 3.8 x 10-3 
dm MD M clearance rate hour- 1 1.9 x 10-3 
7 Time delay before MD M recruitment hours 12 
M(O) Initial number of MDMs cells 0 
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Figure 6: Numerical simulation of the monocyte-derived macrophage model, Equa-
tions (12)-(18), using initial conditions Po = 103 CFU/ml (dashed-dotted line), Po = 104 
CFU/ml (dashed line), Po = 105 CFU/ml (solid line) , and parameter values in Table 3. 
(a) Bacteria against titer data (squares - 105 CFU/mouse, triangles -106 CFU/mouse), (b) 
proinfiammatory cytokine, (c) neutrophils , (d) monocyte-derived macrophages, (e) debris, 
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numbers of pneumococci (105 CFU jml) , these cells continue to increase until 
a peak is reached 9 days pi (not shown in Figure 6), reducing pneumococ-
cus numbers without achieving complete clearance. This extended infection 
with the resulting prolonging of the neutrophil response (Figure 6c) indicates 
significant inflammation. 
The complexity of our model restricts our ability to fully investigate in-
dividual parameter values; however , perturbations in many of the model pa-
rameters may significantly influence the dynamics of each stage and reflect 
differences in the host and the pathogen. Performing a differential sensitivity 
analysis (see (Bortz and Nelson, 2004; Eslami, 1994; Frank, 1978)) highlights 
several important aspects of the dynamics (details in the Supplementary 
File). 
Changes in bacterial clearance can be the driving force behind a rapid and 
favorable resolution. As such, altering either of the two of the parameters 
controlling clearance, 1N and 1m, influences the dynamics. The importance 
of neutrophils in the early stages of bacterial control is confirmed by the dif-
ferences observed early in the infection with changes in the rate of bacterial 
clearance by neutrophils (1N) (Supplementary Figures Sl and S2). Further-
more, this effect is more pronounced and for high initial inocula (i.e., Po = 105 
CFU jml). On the other hand, changes in the rate of bacterial clearance by 
macrophages (1m) influences dynamics later in the infection and to a lesser 
extent (Supplementary Figures S5 and S6), with little effect when Po = 104 
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and T) are relatively insensitive to changes with intermediate or low initial 
values of pneumococci since these cells only aid bacterial clearance later in 
the infection when bacteria is low. 
Perturbing factors related to inflammation can also result in dynamical 
differences. One important parameter with the ability to alter infection ki-
netics is the rate of neutrophil apoptosis due to bacterial cytotoxicity (dNP ). 
However, for high initial inocula, the kinetic effect of an increase in this 
parameter can be balanced with an increase in the rate of neutrophil re-
cruitment (1]) (Supplementary Figure Sl). Other parameters pertaining to 
inflammation are those which control debris (PI, P2, P3, dD and kD ), but 
these parameters are insensitive for both intermediate (except kD ) and high 
initial initial inocula (Supplementary Figures S7 and S8). 
4. Discussion 
When a pneumococcal infection overcomes the innate immune defenses , 
bacterial pneumonia can result. There are many factors , including viru-
lence of bacterial strain and host defense status, that determine the eventual 
outcome of a bacterial challenge to the lung. Developing a basic model of 
acute pulmonary bacterial infection kinetics that could then be expanded or 
modified to address specific bacterial pathogens would be ideal. However, 
establishing the appropriate simplifications to be made is challenging and no 
generalized model may be sufficient given the variability of immune control 
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We developed a series of models to gain a deeper understanding of how 
the different layers of host defense in the lower respiratory tract, including 
physical barriers, resident cells and recruited cells, combine to fight a pneu-
mococcallung infection and to address the two thresholds observed given the 
inoculum size: establishment and eradication. Through our experiments and 
models, we were able to successfully capture the qualitative behavior of the 
data and identify key steps. 
The initial dose threshold was evident through use of a single equation 
that took into account a decrease in phagocytosis by alveolar macrophages 
as bacterial numbers increase, consistent with the view that these cells are 
sufficient to clear only small densities of pneumococci. Following the first few 
hours of infection, more complicated dynamics occur. With the neutrophil 
model, both clearance or sustained growth of bacteria are possible and are 
dependent on whether alveolar macrophages are engaged in phagocytosis or 
debris removal, which was correlated to the amount of pneumococcal-induced 
neutrophil apoptosis. Thus, alveolar macrophages may playa critical role in 
both establishment and complete eradication of a bacterial infection. 
While the neutrophil response is rapid, pneumococcal-induced apoptosis 
of these cells could result in an equally rapid contraction phase. Normal 
resolution in the lung includes the apoptosis of neutrophils, but this may 
also be a significant source of inflammation if the debris is not efficiently 
cleared. Furthermore, the effects of neutrophil death can be negated with an 
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harmful even though bacterial numbers would not be affected. This effect is 
further enhanced with the appearance of macrophages, which contribute to 
both bacterial clearance and respiratory tract inflammation. 
Understanding the ways that damage to the respiratory tract epithelium 
is accrued during an infection has implications on selecting an appropriate 
antimicrobial for treatment. The strategy of rapid pathogen lysis by antibi-
otics may work against immune controls by amplifying inflammatory process 
leading to adverse outcomes. Cell lysis results in the release of bacterial 
products (e.g. , cytotoxins, DNA, and cell-wall components) which are recog-
nized by the innate immune system and trigger inflammation (McCullers and 
Tuomanen, 2001; Orman and English, 2000). Therefore, nonlytic antibiotics 
may improve the outcome possibly by exhibiting antiinflammatory activities 
that complement the antimicrobial actions (Ivetic Tkalcevic et al. , 2006). 
Although we did not study the implications of antibiotics or the complete 
feedback of damage to the cellular response, our model could be extended 
to find alternative treatment strategies that effectively eliminate pathogens 
without increasing pathogenesis. 
The signal triggering the macrophage influx into the lung has yet to be 
fully understood. Delayed macrophage recruitment following neutrophils can 
predict the behavior of pneumococcus in mice suggesting that an intermedi-
ate variable may be responsible. Our model generates consistent results by 
assuming that the signal originates from neutrophils. However, this is likely 






University of Utah Institutional Repository 
Author Manuscript 
The phagocytic response is essential for successful clearance; however, 
other factors may contribute to pneumococcal removal. For example, a 
polysaccharide capsule renders this bacterium resistant to engulfment by 
phagocytic cells, but antibodies bound to the polysaccharide negate this 
effect by acting as ligands between the bacteria and phagocyte thereby in-
creasing phagocytic efficiency (van Dam et al., 1990). Furthermore, anti-
bodies activate the classical complement pathway (Paterson and Mitchell, 
2006), which is thought to be a key step leading to elimination of pneumo-
cocci (Kerr et al. , 2005). More recent evidence suggests that IL-1 7 -secreting 
CD4+ T-cells are involved in the neutrophil-mediated immune response and 
may also help prevent colonization (Lu et al., 2008). However , relatively little 
is known regarding the influence of these cells, which may have only minimal 
effects on an initial infection in a naive individual. 
Much remains to be discovered concerning the properties of bacterial rise , 
dissemination, and clearance within a host. Mathematical models provide a 
means of evaluating relative contributions of individual immune components 
to the processes during a bacterial infection with pneumococci. Using the-
oretical analyses to compare host responses in different patient populations 
will help determine why some individuals never get sick while others are eas-
ily colonized. Even models with moderate complexity like ours are important 
tools for the assessment of host responses. As more data becomes available, 
model formulations can become more refined and parameter values can be es-
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of pneumococcal infections. 
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